Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12756 | 883 | 27.3 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
537 | 3 | BIOARTIFICIAL LIVER//HEPATOCYTES//HEPATOCYTE TRANSPLANTATION | 19236 |
3543 | 2 | ALKAPTONURIA//OCHRONOSIS//HOMOGENTISIC ACID | 1359 |
12756 | 1 | TYROSINEMIA//SUCCINYLACETONE//NTBC | 883 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TYROSINEMIA | authKW | 1400459 | 6% | 75% | 54 |
2 | SUCCINYLACETONE | authKW | 985112 | 4% | 81% | 35 |
3 | NTBC | authKW | 806064 | 3% | 90% | 26 |
4 | TYROSINEMIA TYPE I | authKW | 619869 | 2% | 81% | 22 |
5 | SULCOTRIONE | authKW | 603564 | 3% | 73% | 24 |
6 | 4 HYDROXYPHENYLPYRUVATE DIOXYGENASE | authKW | 540292 | 3% | 63% | 25 |
7 | FUMARYLACETOACETATE HYDROLASE | authKW | 508312 | 2% | 70% | 21 |
8 | TYROSINEMIA TYPE II | authKW | 449539 | 1% | 100% | 13 |
9 | MESOTRIONE | authKW | 420531 | 3% | 41% | 30 |
10 | HEREDITARY TYROSINEMIA TYPE 1 | authKW | 389597 | 1% | 87% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Genetics & Heredity | 1785 | 20% | 0% | 173 |
2 | Medicine, Research & Experimental | 984 | 13% | 0% | 118 |
3 | Pediatrics | 876 | 12% | 0% | 103 |
4 | Endocrinology & Metabolism | 518 | 10% | 0% | 92 |
5 | Medical Laboratory Technology | 343 | 4% | 0% | 31 |
6 | Biochemistry & Molecular Biology | 307 | 19% | 0% | 171 |
7 | Dermatology | 73 | 3% | 0% | 24 |
8 | Chemistry, Medicinal | 63 | 3% | 0% | 29 |
9 | Entomology | 55 | 2% | 0% | 21 |
10 | Biochemical Research Methods | 46 | 3% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MIDWEST FETAL CARE | 69160 | 0% | 100% | 2 |
2 | ERROS INATOS METAB | 36267 | 1% | 13% | 8 |
3 | GENET CELLULAIRE DEV | 36013 | 1% | 21% | 5 |
4 | ALLGEMEINE KINDERHEILKUNDE JUGENDMED | 34580 | 0% | 100% | 1 |
5 | AUTON UNIV MADRID | 34580 | 0% | 100% | 1 |
6 | BIOC TEURS ANALYSE ENVIRONM | 34580 | 0% | 100% | 1 |
7 | BIOCHEM GENET CLIN | 34580 | 0% | 100% | 1 |
8 | C FSIP | 34580 | 0% | 100% | 1 |
9 | CENT CHEM PESTICIDE | 34580 | 0% | 100% | 1 |
10 | CHILD HLTHBIOCHEM GENET UNIT | 34580 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF INHERITED METABOLIC DISEASE | 31266 | 7% | 1% | 64 |
2 | MOLECULAR GENETICS AND METABOLISM | 3563 | 2% | 1% | 18 |
3 | BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY | 796 | 0% | 1% | 4 |
4 | CLINICA CHIMICA ACTA | 777 | 2% | 0% | 16 |
5 | PEDIATRIC RESEARCH | 619 | 1% | 0% | 13 |
6 | HUMAN MUTATION | 543 | 1% | 0% | 8 |
7 | PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY | 538 | 1% | 0% | 7 |
8 | PEST MANAGEMENT SCIENCE | 536 | 1% | 0% | 7 |
9 | AMERICAN JOURNAL OF HUMAN GENETICS | 502 | 1% | 0% | 11 |
10 | ORPHANET JOURNAL OF RARE DISEASES | 491 | 0% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TYROSINEMIA | 1400459 | 6% | 75% | 54 | Search TYROSINEMIA | Search TYROSINEMIA |
2 | SUCCINYLACETONE | 985112 | 4% | 81% | 35 | Search SUCCINYLACETONE | Search SUCCINYLACETONE |
3 | NTBC | 806064 | 3% | 90% | 26 | Search NTBC | Search NTBC |
4 | TYROSINEMIA TYPE I | 619869 | 2% | 81% | 22 | Search TYROSINEMIA+TYPE+I | Search TYROSINEMIA+TYPE+I |
5 | SULCOTRIONE | 603564 | 3% | 73% | 24 | Search SULCOTRIONE | Search SULCOTRIONE |
6 | 4 HYDROXYPHENYLPYRUVATE DIOXYGENASE | 540292 | 3% | 63% | 25 | Search 4+HYDROXYPHENYLPYRUVATE+DIOXYGENASE | Search 4+HYDROXYPHENYLPYRUVATE+DIOXYGENASE |
7 | FUMARYLACETOACETATE HYDROLASE | 508312 | 2% | 70% | 21 | Search FUMARYLACETOACETATE+HYDROLASE | Search FUMARYLACETOACETATE+HYDROLASE |
8 | TYROSINEMIA TYPE II | 449539 | 1% | 100% | 13 | Search TYROSINEMIA+TYPE+II | Search TYROSINEMIA+TYPE+II |
9 | MESOTRIONE | 420531 | 3% | 41% | 30 | Search MESOTRIONE | Search MESOTRIONE |
10 | HEREDITARY TYROSINEMIA TYPE 1 | 389597 | 1% | 87% | 13 | Search HEREDITARY+TYROSINEMIA+TYPE+1 | Search HEREDITARY+TYROSINEMIA+TYPE+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DUMAS, E , GIRAUDO, M , GOUJON, E , HALMA, M , KNHILI, E , STAUFFERT, M , BATISSON, I , BESSE-HOGGAN, P , BOHATIER, JT , BOUCHARD, P , ET AL (2017) FATE AND ECOTOXICOLOGICAL IMPACT OF NEW GENERATION HERBICIDES FROM THE TRIKETONE FAMILY: AN OVERVIEW TO ASSESS THE ENVIRONMENTAL RISKS.JOURNAL OF HAZARDOUS MATERIALS. VOL. 325. ISSUE . P. 136 -156 | 87 | 52% | 0 |
2 | SANTRA, S , BAUMANN, U , (2008) EXPERIENCE OF NITISINONE FOR THE PHARMACOLOGICAL TREATMENT OF HEREDITARY TYROSINAEMIA TYPE 1.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 9. ISSUE 7. P. 1229-1236 | 46 | 94% | 19 |
3 | PITKANEN, ST , SALO, MK , HEIKINHEIMO, M , (2000) HEREDITARY TYROSINAEMIA TYPE I: FROM BASICS TO PROGRESS IN TREATMENT.ANNALS OF MEDICINE. VOL. 32. ISSUE 8. P. 530 -538 | 62 | 86% | 9 |
4 | MAYORANDAN, S , MEYER, U , GOKCAY, G , SEGARRA, NG , DE BAULNY, HO , VAN SPRONSEN, F , ZEMAN, J , DE LAET, C , SPIEKERKOETTER, U , THIMM, E , ET AL (2014) CROSS-SECTIONAL STUDY OF 168 PATIENTS WITH HEPATORENAL TYROSINAEMIA AND IMPLICATIONS FOR CLINICAL PRACTICE.ORPHANET JOURNAL OF RARE DISEASES. VOL. 9. ISSUE . P. - | 35 | 95% | 12 |
5 | RUSSO, PA , MITCHELL, GA , TANGUAY, RM , (2001) TYROSINEMIA: A REVIEW.PEDIATRIC AND DEVELOPMENTAL PATHOLOGY. VOL. 4. ISSUE 3. P. 212-221 | 57 | 81% | 73 |
6 | ZEYBEK, ACA , KIYKIM, E , SOYUCEN, E , CANSEVER, S , ALTAY, S , ZUBARIOGLU, T , ERKAN, T , AYDIN, A , (2015) HEREDITARY TYROSINEMIA TYPE 1 IN TURKEY: TWENTY YEAR SINGLE-CENTER EXPERIENCE.PEDIATRICS INTERNATIONAL. VOL. 57. ISSUE 2. P. 281 -289 | 33 | 94% | 4 |
7 | MCKIERNAN, PJ , (2006) NITISINONE IN THE TREATMENT OF HEREDITARY TYROSINAEMIA TYPE 1.DRUGS. VOL. 66. ISSUE 6. P. 743-750 | 38 | 97% | 39 |
8 | GROMPE, M , (2001) THE PATHOPHYSIOLOGY AND TREATMENT OF HEREDITARY TYROSINEMIA TYPE 1.SEMINARS IN LIVER DISEASE. VOL. 21. ISSUE 4. P. 563-571 | 53 | 77% | 63 |
9 | DE LAET, C , DIONISI-VICI, C , LEONARD, JV , MCKIERNAN, P , MITCHELL, G , MONTI, L , DE BAULNY, HO , PINTOS-MORELL, G , SPIEKERKOTTER, U , (2013) RECOMMENDATIONS FOR THE MANAGEMENT OF TYROSINAEMIA TYPE 1.ORPHANET JOURNAL OF RARE DISEASES. VOL. 8. ISSUE . P. - | 29 | 94% | 24 |
10 | NASRALLAH, F , HAMMAMI, MB , BEN RHOUMA, H , FRADJ, SH , AZZOUZ, H , OMAR, S , FEKI, M , BEN YOUSSEF, IT , MESSAOUD, T , TEBIB, N , ET AL (2015) CLINICAL AND BIOCHEMICAL PROFILE OF TYROSINEMIA TYPE 1 IN TUNISIA.CLINICAL LABORATORY. VOL. 61. ISSUE 5-6. P. 487 -492 | 29 | 100% | 0 |
Classes with closest relation at Level 1 |